Roy Bannister
Gilead Sciences (United States)
ORCID: 0000-0002-6311-1440Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 8 papers. Top paper: “The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses”.
Fernando R. Moreira, Nicholas Catanzaro, Meghan V. Diefenbacher, Mark R. Zweigart, Kendra L. Gully +27 more
Yeojin Park, Richard L. MacKman, Roy Bannister, Dustin S. Siegel, Tomáš Cihlář +18 more
Rao Kalla, Mark R. Zweigart, Tomáš Cihlář, Jennifer H. Tang, Richard L. Mackman +23 more
Laharika Dasharath Katamoni, Jacqueline Brockhurst, Shristi Ghimire, San Suwanmanee, Lisa Pieterse +7 more
Fernando R. Moreira, Mark R. Zweigart, Kendra L. Gully, Gabriela De la Cruz, Ariane J. Brown +25 more
Samantha R. May, Joy Y. Feng, Ariane J. Brown, Kendra L. Gully, Tomáš Cihlář +27 more
Courtney Woolsey, Abhishek N. Prasad, Viktoriya Borisevich, Krystle N. Agans, Daniel J. Deer +11 more
David R. Martinez, John J. Won, Fernando R. Moreira, Ariane J. Brown, Kendra L. Gully +18 more